Novocure (NSDQ:NVCR) shares took a sharp dip on fourth-quarter results that came up short of the consensus forecast. NVCR shares were down 12.7% at $63.70 per share in early-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was down 1.3%. The St. Helier, Jersey-based company […]
NovoCure
These medtech companies care a lot about research
They’re making glaucoma-treating stents, tumor-treating fields, coin-sized CGMs and more. Discover the medtech companies that spend the most on research as a percentage of revenue. The list comes from our annual Big 100 report, which examines the world’s 100 largest medical device companies and ranks them by revenue. (Check out our full Big 100 report […]
Novocure signs agreement to build development facility in New Hampshire
Novocure (NSDQ:NVCR) announced today that it signed a purchase and sale agreement for an office building in Portsmouth, New Hampshire. The agreement covers the acquisition and construction of the building at 64 Vaughan Mall, situated centrally in downtown Portsmouth. The purchase price for the property totals $9.5 million and, after closing (expected on or before […]
How medtech fared in the first waves of the pandemic
Medtech industry revenue, research spending and employment declined in the first year of the COVID-19 pandemic, according to a Medical Design & Outsourcing analysis of financial data. Total sales, R&D spending and employment for the world’s largest medical device companies declined in 2020 and early 2021, according to a Medical Design & Outsourcing analysis tallying the ongoing pandemic’s initial […]
Novocure slides on Q3 earnings, revenue misses
Novocure (NSDQ:NVCR) shares slid this morning on third-quarter results that fell short the consensus forecast. NVCR shares were down -7.3% at $102.68 per share in mid-morning trading. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — remained virtually unchanged. The St. Helier, Jersey-based developer of electric fields for […]
Novocure wins FDA breakthough designation for liver tumor treatment device
Novocure (NSDQ:NVCR) announced today that the FDA granted breakthrough designation for its NovoTTF-200T liver cancer treatment system. St. Helier, Jersey-based Novocure designed its NovoTTF-200T system, a tumor treating fields (TTFields) delivery system for use in tandem with atezolizumab and bevacizumab for the first-line treatment of patients with unresectable or metastatic liver cancer. According to a […]
Novocure plummets on missed Q2 projections
Novocure (NSDQ:NVCR) shares took a dive today on second-quarter results that came up short of the consensus forecast. NVCR shares were down -11.7% at $160.67 in mid-afternoon trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was up 0.9% on the day. Get the full story at our sister […]
MedTech 100 roundup: Stocks show no signs of slowing down
The medtech industry hit further highs in the market last week and the stocks show no sign of stopping their ascent now. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week at 97.62 (Nov. 6), marking a 7.3% leap from the 91.01 points registered at the […]
Novocure closes $575M offering
NovoCure (NSDQ:NVCR) announced that it closed its previously announced offering of $575 million in 0% convertible senior notes. The notes, due in 2025, are set to bring in net proceeds of approximately $558.4 million after the initial purchasers exercised full their option to purchase an additional $75 million in notes, according to a news release from […]
COVID-19 upends medtech’s financial outlook
The uncertain times brought on by the COVID-19 pandemic have affected businesses worldwide, and several sectors of medtech industry are projecting hits to their bottom lines. A number of companies have announced decisions to withdraw financial guidance, cut hours and/or staff, among other major business decisions. Initial impacts of the global pandemic on Wall Street […]
Novocure’s Optune wins innovative medical device designation from China
NovoCure (NSDQ:NVCR) said today that it was granted Innovative Medical Device Designation in China for its Optune tumor treating system. The Optune system uses electric fields that are tuned in to specific frequencies to disrupt cancer cell division, according to the company. The technology inhibits tumor growth and causes cancer cells to die. Zai Lab has […]
